-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Background: Despite success in reducing the risk of diabetic complications over the past few decades, type 1 diabetes is still associated with an increased risk of premature death compared with matched individuals in the general populati.
Background: Despite success in reducing the risk of diabetic complications over the past few decades, type 1 diabetes is still associated with an increased risk of premature death compared with matched individuals in the general populati.
Objectives: In the current study, we explored whether there are prognostic differences between a history of CVD and nontraumatic LLA in terms of risk of all-cause mortality in patients with long-term type 1 diabet.
METHODS: We used pooled data from prospective cohorts of SURGENE, GENEDIAB and GENES.
Results: Among 1169 participants (55% male, age 40±13 years, duration of diabetes 23±11 years), 49 (2%), 62 (3%) and 20 (7%) were affected, respective.
Table 1 Baseline participant characteristics by incidence of all-cause mortality during follow-up
Figure 1 Kaplan Meier curve estimates of survival based on baseline history of cardiovascular disease (CVD) and lower extremity amputation (LLA): no cardiovascular disease (green line), cardiovascular disease only (red line), LLA only (blue line), and cardiovascular disease Disease and LLA (black lin.
Figure 1 Kaplan Meier curve estimates of survival based on baseline history of cardiovascular disease (CVD) and lower extremity amputation (LLA): no cardiovascular disease (green line), cardiovascular disease only (red line), LLA only (blue line), and cardiovascular disease Disease and LLA (black lin.
Table 2 Risk of all-cause mortality with history of cardiovascular disease or/and LLA at baseline during follow-up
Conclusions: Cardiovascular disease and LLA caused a similar mortality burden in the type 1 diabetes populati.
Conclusions: Cardiovascular disease and LLA caused a similar mortality burden in the type 1 diabetes populati.
Original source: Camoin M, Velho G, Saulnier PJ, et .
Differential prognostic burden of cardiovascular disease and lower-limb amputation on the risk of all-cause death in people with long-standing type 1 diabet.
Cardiovasc Diabetol 2022 May 09; 21(1) Differential prognostic burden of cardiovascular disease and lower-limb amputation on the risk of all-cause death in people with long-standing type 1 diabet.
Leave a comment here